Effects of drug countermeasures for space motion sickness on working memory in humans

Neurotoxicology and Teratology

Volumn 26, Issue 6 SPEC. ISS., 2004, Pages 825-837

  Paule, Merle G ^a   Chelonis, John J ^b   Blake, Donna J ^c   Dornhoffer, John L ^c  

^a Behavioral Toxicology Laboratories   (United States)

^b UNIVERSITY OF ARKANSAS AT LITTLE ROCK   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Delayed matching to sample; Lorazepam; Meclizine; Promethazine; Scopolamine; Short term memory

Indexed keywords

ANTIVERTIGO AGENT; LORAZEPAM; MECLOZINE; PROMETHAZINE; SCOPOLAMINE;

ADULT; CLINICAL TRIAL; COGNITION; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COSMONAUT; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GRAVITATIONAL STRESS; HUMAN; MALE; MOTION SICKNESS; NORMAL HUMAN; PRIORITY JOURNAL; SPACE FLIGHT; TASK PERFORMANCE; VESTIBULAR STIMULATION; VISUAL MEMORY; WORKING MEMORY;

EID: 4644250479     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2004.07.002     Document Type: Conference Paper

References (38)

1. W. Abeln, H. Bienhold, and H. Flohr Influence of cholinomimetics and cholinolytics on vestibular compensation Brain Res. 222 1981 458 462
2. R. Baloh The dizzy patient, symptomatic treatment of vertigo Postgrad. Med. 73 1983 317 324
3. A.J. Benson Possible mechanisms of motion and space sickness Life-Sciences Research in Space 1977 European Space Agency Paris Report SP-130
4. A.J. Benson M.R. Dix J.D. Hood Vertigo 1984 John Wiley and Sons Chichester
5. J.J. Chelonis, J.L. Daniels-Shaw, D.J. Blake, and M.G. Paule Developmental aspects of delayed matching-to-sample task performance in children Neurotoxicol. Teratol. 22 2000 683 694
6. P.S. Cowlings, W.B. Toscano, C. DeRoshia, and N.E. Miller Promethazine as a motion sickness treatment: impact on human performance and mood states Aviat. Space Environ. Med. 71 2000 1013 1022
7. J.R. Davis, J.M. Vanderpoeg, P.A. Santy, R.T. Jennings, and D.F. Stewart Space motion sickness during 24 flights of the space shuttle Aviat. Space Environ. Med. 59 1988 1185 1189
8. J.L. Dornhoffer, J.J Chelonis, and D.J. Blake Pharmacologic countermeasures in space motion sickness Otol. Neurotol. 2004 (in press)
9. A. Graybiel, and J.R. Lackner Rotation at 30 rpm about the Z-axis after 6 h in the 10° head-down position: effect on susceptibility to motion sickness Aviat. Space Environ. Med. 50 1979 390 392
10. A-benzodiazepine receptor: biology and pharmacology G. Burrows M. Roth R. Noyes The Neurobiology of Anxiety 1990 Elsevier Amsterdam 165 188
11. T.C. Hain Treatment of vertigo Neurologist 1 1995 125 133
12. J.L. Homick, M.F. Reschke, J.M. Vanderploeg, Space adaptation syndrome: incidence and operational implications for the space transportation system program. Symposium on Motion Sickness: Mechanisms, prediction, prevention and treatment. AGARD/NATO Conference Proceedings 372; Neuilly-sur Seine, 1984, pp. 36-1 to 36-6.
13. R.T. Jennings Managing space motion sickness J. Vestib. Res. 8 1997 67 70
14. K. Kawasaki, A. Matsushita, M. Satoh, and H. Takagi The lateral vestibular nucleus is a site for the depressant action of benzodiazepines on the crossed extensor reflex Brain Res. 461 1988 282 289
15. J.R. Lackner, and P. DiZio Gravitational, inertial, and coriolis force influences on nystagmus, motion sickness, and perceived head trajectory A. Berthoz W. Graf P.P. Vidal The Head-Neck Sensory-Motor Symposium 1992 Oxford University Press New York 216 222
16. B. McCabe, T. Sekitani, and J. Tyy Drug effects on labyrinthectomy nystagmus Arch. Otolaryngol. 98 1973 309 314
17. K.E. Money, J.D. Wood, Neural mechanisms underlying the symptomatology of motion sickness, Defense Research Establishment Toronto, Review Paper 720, 1970.
18. NAS, National Academy of Science A strategy for research in space biology and medicine into the next century 1998
19. C.M. Oman Spacelab experiments on space motion sickness Acta Astronaut. 1 1987 55 66
20. M.G. Paule, J.J. Chelonis, E.A. Buffalo, D.J. Blake, and P.H. Casey Operant Test Battery Performance in children: correlation with IQ Neurotoxicol. Teratol. 21 1999 223 230
21. M.G. Paule, P.J. Bushnell, J.P.J. Maurissen, G.R. Wenger, J.J. Buccafusco, J.J. Chelonis, and R. Elliott Symposium overview: the use of delayed matching-to-sample procedures in studies of short-term memory in animals and humans Neurotoxicol. Teratol. 20 1998 493 502
22. S. Peppard Effect of drug therapy on compensation from vestibular injury Laryngoscope 96 1986 878 898
23. B.J.W. Pingree Motion commotion: a seasickness update J. R. Nav. Med. Serv. 75 1989 75 84
24. B.J.W. Pingree Space motion sickness J. R. Nav. Med. Serv. 76 1990 25 32
25. T.W. Rall Hypnotics and sedatives; ethanol A. Gilman T. Rall A. Nies Good Man and Gilman's the Pharmacological Basis of Therapeutics 1990 Pergamon Press New York 345 382
26. O. Rascol, T.C. Hain, C. Brefel, M. Benazet, M. Clanet, and J.-L. Montastruc Antivertigo medications and drug-induced vertigo: a pharmacological review Drugs 50 1995 777 791
27. J.T. Reason Motion sickness adaptation: a neural mismatch model J. R. Soc. Med. 71 1976 819 829
28. J.T. Reason, and J.J. Brand Motion Sickness 1975 Academic Press London
29. M.F. Reschke, D.L. Harm, D.E. Parker, G.R. Sandoz, J.L. Homick, and J.M. Vanderpoeg Neurophysiologic aspects: Space motion sickness A.E. Nicogossian C.L. Huntoon S.L. Pool Space Physiology and Medicine 3rd ed. 1994 Lea and Febiger Philadelphia 228 260
30. J. Ryn, and B. McCabe Effect of diazepam and dimenhydrinate on the resting activity of the vestibular neuron Aeros. Med. 45 1974 1177 1179
31. K. Schaefer, and D. Meyer Aspects of vestibular compensation in guinea pigs H. Flohr W. Precht Lesion-induced Neuronal Plasticity in Sensorimotor Systems 1981 Springer Berlin 197 207
32. W.E. Thornton, T.P. Moore, S.L. Pool, and J.M. Vanderploeg Clinical characterization and etiology of space motion sickness Aviat. Space Environ. Med. 58 9, Suppl. 1987 A1 A8
33. C.D. Wood, and A. Graybiel A theory of motion sickness based on pharmacological reactions Clin. Pharmacol. Ther. 11 1970 621 629
34. C.D. Wood, J.J. Stewart, M.J. Wood, J.E. Manno, B.R. Manno, and M.E. Mims Therapeutic effects of antimotion sickness medications on the secondary symptoms of motion sickness Aviat. Space Environ. Med. 61 1990 157 161
35. C.D. Wood, J.J. Stewart, M.J. Wood, and M. Mims Effectiveness and duration of intramuscular antimotion sickness medications J. Clin. Pharmacol. 32 1992 1008 1012
36. J. Woods, J. Katz, and G. Winger Abuse and therapeutic use of benzodiazepines and benzodiazepine-like drugs F. Bloom D. Kuppler Psychopharmacology, the Fourth Generation of Progress 1995 Raven Press New York 1777 1791
37. B.J. Yates, A.D. Miller, and J.B. Lucot Physiological basis and pharmacology of motion sickness: an update Brain Res. Bull. 47 1998 395 406
38. D. Zee Perspectives on the pharmacotherapy of vertigo Arch. Otolaryngol. 111 1985 609 612